相关实验视频
Updated: Jul 12, 2025
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
前列腺癌中的微RNA:对治疗反应和治疗点的影响
Mohamed Ali Hussein1,2, Gnanasekar Munirathinam3
1Department of Pharmaceutical Services, Children's Cancer Hospital Egypt 57357, Cairo 11562, Egypt.
Cancers
|October 28, 2023
概括
抗癌治疗阻力是治愈癌症的一个主要障碍. 了解和克服这种抵抗对于开发有效的癌症疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 药物耐药性机制 药物耐药性机制
背景情况:
- 癌症治疗耐药性是一个重大的全球健康挑战.
- 它阻碍了许多治疗策略的有效性.
- 开发新的方法来克服阻力是关键的.
研究的目的:
- 研究癌症治疗耐药性的潜在机制.
- 识别潜在的治疗目标,以克服抗药性.
- 推动开发更有效的癌症治疗方法.
主要方法:
- 对癌症耐药性的当前文献的综述.
- 临床前和临床研究的分析.
- 探索新出现的抵抗路径.
主要成果:
- 抵抗机制是多样化和复杂的,涉及遗传和表观遗传改变.
- 特定的途径已被确定为阻力的主要驱动因素.
- 组合疗法在临床前模型中显示出前景.
结论:
- 更深入地了解耐药生物学是必不可少的.
- 针对抗药性机制提供了一种可行的策略,以改善治疗结果.
- 需要进一步的研究才能将这些发现转化为临床实践.
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K